Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002016056-24-000003
Filing Date
2024-04-05
Accepted
2024-04-05 12:27:23
Documents
1
Effectiveness Date
2024-04-05
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11915
  Complete submission text file 0002016056-24-000003.txt   13085
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-509788 | Film No.: 24825698
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)